Low Intensity Physical Activity in Congestive Heart Failure Patients Among Different BMI

NCT ID: NCT07062900

Last Updated: 2025-07-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-28

Study Completion Date

2025-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examined the effects of low-intensity physical activity on functional capacity, quality of life, and psychological well-being in congestive heart failure patients with varying BMI. Forty patients were divided into intervention and control groups. The intervention group followed an 8-week physical activity program, while the control group received usual care. Results showed significant improvement in walk distance, quality of life, and depression scores in the intervention group. The study concludes that low-intensity physical activity effectively improves health outcomes in heart failure patients across different BMI categories.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized controlled trial explored the effects of low-intensity physical activity on functional capacity, quality of life, and psychological well-being in patients with congestive heart failure across different BMI categories. A total of forty patients were selected and randomly assigned to either an intervention group or a control group. The intervention group participated in an eight-week structured low-intensity physical activity program, while the control group continued with usual care without additional physical activity. Various assessment tools were used to evaluate outcomes, including the 6-minute walk test to measure functional capacity, the Kansas City Cardiomyopathy Questionnaire to assess quality of life, and the Hospital Anxiety and Depression Scale to evaluate psychological well-being. The results demonstrated that although both groups showed some improvement, the intervention group experienced significantly greater gains in all measured outcomes. The 6-minute walk distance increased, KCCQ-12 scores improved notably, and depressive symptoms reduced significantly in the intervention group compared to the control. The study concluded that low-intensity physical activity is an effective and feasible intervention to enhance physical and mental health in congestive heart failure patients, irrespective of their BMI category.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low-Intensity Physical Activity Group

Participants in this group underwent an 8-week structured low-intensity physical activity program. The program included gentle walking, use of a portable pedal exerciser, light resistance band exercises, and functional activities like seated leg press and hip circles. Sessions gradually increased in duration and frequency, starting from 2 sessions per week to 3 sessions per week, lasting 20-40 minutes each. The focus was on improving functional capacity, psychological well-being, and quality of life without causing cardiac stress.

Group Type EXPERIMENTAL

Low-Intensity Physical Activity

Intervention Type BEHAVIORAL

This includes a structured and progressive 8-week physical activity program involving:

Gentle walking

Portable pedal exerciser

Low-intensity resistance exercises (e.g., resistance bands, seated leg press, hip circles)

Supervised sessions with warm-up and cool-down components

usual care

Intervention Type BEHAVIORAL

Standard Medical Management: Participants continued with their prescribed medications and routine clinical follow-ups for congestive heart failure as directed by their healthcare providers.

Usual Care Group

Participants in this group received standard medical care only, with no additional structured physical activity or intervention. They continued their routine treatment and lifestyle without any specific exercise regimen. This group served as the comparison group to evaluate the effects of the physical activity intervention.

Group Type ACTIVE_COMPARATOR

usual care

Intervention Type BEHAVIORAL

Standard Medical Management: Participants continued with their prescribed medications and routine clinical follow-ups for congestive heart failure as directed by their healthcare providers.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low-Intensity Physical Activity

This includes a structured and progressive 8-week physical activity program involving:

Gentle walking

Portable pedal exerciser

Low-intensity resistance exercises (e.g., resistance bands, seated leg press, hip circles)

Supervised sessions with warm-up and cool-down components

Intervention Type BEHAVIORAL

usual care

Standard Medical Management: Participants continued with their prescribed medications and routine clinical follow-ups for congestive heart failure as directed by their healthcare providers.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospitalized Congestive heart failure patients
* Age 45-70
* Diagnosed with CHF
* BMI all ranges
* Severely underweight: BMI\<16 kg/m2
* Underweight: BMI≥ 16 kg/m2 and \<18.5 kg/m2
* Normal weight BMI≥18.5 kg/mg2 and \<25kg/m2
* Overweight: BMI ≥25kg/m2 and\<30 kg/m2
* Obese: BMI≥30 kg/m2
* Willing to participate in physical activity program

Exclusion Criteria

* Musculoskeletal or neurological disorders
* Severe COPD or other respiratory diseases
* Cognitive impairment
* Cardiac catheter related surgery, valvular surgery within past 6 month
* Recent Lung embolis
* Lung cancer
* Participants in other clinical trial or intervention study
Minimum Eligible Age

45 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arjumand Bano, Ms CPPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arjumand

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

imran amjad, phd

Role: CONTACT

03324390125

Arjumand Bano, Ms CPPT

Role: CONTACT

03059551883

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Arjumand Bano, MS-CPPT

Role: primary

03059551883

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/RCR&AHS/24/0360

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.